David Whiting

Finasteride in the treatment of men with androgenetic alopecia

Keith D. Kaufman, Elise A. Olsen, David Whiting et al. · Journal of the American Academy of Dermatology · 1998 · 752 citations

Andrology, Clinical Dermatology, Skin Pharmacology +5

Activation of progelatinase A (MMP‐2) by neutrophil elastase, cathepsin G, and proteinase‐3: A role for inflammatory cells in tumor invasion and angiogenesis

Peter Shamamian, Jess D. Schwartz, Ben J.Z. Pocock et al. · Journal of Cellular Physiology · 2001 · 352 citations

Desmoglein 4 in Hair Follicle Differentiation and Epidermal Adhesion

Ana Kljuic, Hisham Bazzi, John P. Sundberg et al. · Cell · 2003 · 322 citations · Full text

Skin Development, Developmental Biology, Morphogenesis +4

Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials

Mark Lebwohl, Scott M. Dinehart, David Whiting et al. · Journal of the American Academy of Dermatology · 2004 · 290 citations

Ophthalmology, Imiquimod 5, Phase Iii +7

The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride

Elise A. Olsen, Maria Hordinsky, David Whiting et al. · Journal of the American Academy of Dermatology · 2006 · 287 citations

Dual 5α-Reductase Inhibition, Medicine, Randomized Placebo-controlled Study +6